Capsule Endoscopy Market, By Accessories, By Endoscope Type, By Product, By Application, By End Use, and By Geography - Analysis, Size, Share, Trends, & Forecast from 2020-2026
発行: AnalystView Market Insights
ページ情報: 英文 210 Pages
世界のカプセル内視鏡の市場は2019年の6億7130万米ドルから、予測期間中は8.4％のCAGRで成長すると予測されています。消化器疾患などの慢性疾患や癌の有病率の増加が同市場の成長を推進しています。米国癌研究協会 (AICR) によると、男性では大腸癌が3番目、胃癌が4番目に起こりやすい癌とされており、一方、女性では、大腸癌は2番目、胃癌は7番目に多く発生している癌とされています。世界保健機関（WHO）のデータによると、大腸癌の2018年における新規登録患者数は1,849,518人で、全体の10.2％のシェアを占めています。このような高い罹患率がカプセル内視鏡の需要を推進し、市場成長を牽引するものと予測されています。
Capsule Endoscopy Market, By Accessories (Workstation & Receiver and Wireless Capsule), By Endoscope Type (Capsule Cystoscopies and Capsule Neuro-Endoscopes), By Product (Colon, Esophageal, and Small Bowel), By Application (Small Intestine Tumor, Crohn's Disease, and OGIB), By End Use (Hospital, Pathology Laboratories, and Outpatient Centre), and By Geography (EU, NA, APAC, LATAM, and MEA) - Analysis, Size, Share, Trends, & Forecast from 2020-2026.
The capsule endoscopy market was valued at USD 671.3 million by 2019, growing with 8.4% CAGR during the forecast period, 2020-2026.
Capsule endoscopy is a minimally invasive procedure that allows complete examination of the gastrointestinal (GI) tract with the help of a disposable, and wireless device, known as a video capsule. This technology has revolutionized the approach to small intestinal disease management and investigation. The capsule is equipped with a light source, transmitter, battery, and camera. This tiny device captures images in the small intestine, stomach, and esophagus, which are utilized for the diagnosis of GI diseases. The endoscopy procedure is also used for the visualization of the inside area of the digestive tract and intestines. Capsule endoscopy is mainly indicated for the patients with tumors, ulcers, inflammatory bowel disease, and polyps of the small intestine.
Globally, increasing the prevalence of chronic diseases such as gastrointestinal and cancer is the major factor driving the growth of the worldwide capsule endoscopy market. According to the American Institute for Cancer Research (AICR), in men, colorectal cancer is the third most, and stomach cancer is the fourth most commonly occurring cancer. While in women, colorectal cancer is the second most, and stomach cancer is the seventh most commonly occurring cancer. As per the World Health Organization's Globocan 2018 data, colorectum accounted for a 10.2% share of all cancer types with 1,849,518 registered new cases in 2018. Such a high incidence rate would, in turn, fuels the demand for capsule endoscopy among the patient population, driving the industry growth.
Furthermore, the growing geriatric population bases that are prone to GIT diseases such as appendicitis and inflammatory bowel condition will boost the industry growth. Additionally, the rising demand for minimally invasive procedures and favorable reimbursement policies for endoscopic procedures will propel the demand for capsule endoscopy procedures. However, lack of availability of skilled technicians and high costs of advanced capsule endoscopes are predicted to restrict the market growth. On the contrary, the rising investments by major industry players in R&D activities and technological advancements will offer lucrative growth opportunities for market development in the coming future.
"Wireless capsule segment to provide lucrative growth opportunities by the end of 2026"
Based on the accessories, the global capsule endoscopy market is bifurcated into wireless capsule endoscopy (WCE) and workstation & receiver. Of these, the WCE segment accounted for the largest market share with more than 80% share of the global market in 2019. This is mainly due to the wide usage of wireless capsules for various medical conditions such as esophageal cancer, small bowel disease, and others. Moreover, wireless capsules have several advantages such as greater battery life, larger frame rate, and panoramic view, and are thus, gaining popularity in the market. Besides, recent advancements in WCE technology by key players have made possible the investigation of both the distal and proximal parts of the gut using designed devices.
Endoscope Type Takeaway
"Capsule neuro-endoscopes segment registered for substantial market share in 2019"
On the basis of the endoscope type, the overall market for capsule endoscopy is bifurcated into capsule cystoscopies and neuro-endoscopes. Among these, the capsule neuro-endoscopes category recorded the majority of market share in 2019. This is mainly because of neuro-endoscope capsules aid physicians in evaluating critical GI parts by using advanced visualization systems. Moreover, neuro-endoscope capsules are beneficial due to their operating and ergonomics outcomes. Besides, reimbursement and cost benefits of these capsules are likely to augment the segmental market growth in the coming future.
"Small bowel capsule segment to dominate the industry throughout the forecast"
Based on the product, the worldwide market is divided into colon, esophageal, and small bowel. Of these, the small bowel capsule segment subjugated the industry in 2019 and is estimated to play a dominant role during the forecast period. This is mainly because it is the most preferred endoscopy capsules by doctors to see inside the small intestine and examine several medical conditions, such as inflammatory bowel disease, small bowel neoplastic lesions, and others.
On the other hand, the esophageal capsule is projected to register for significant market growth by 2026 owing to the growing prevalence of esophageal cancer. According to the American Institute for Cancer Research (AICR), esophageal cancer is the 7th most commonly prevailing cancer in men and the 13th most common in women. Around 500,000 new cases of esophageal cancer were registered in the U.S. in 2018.
"OBIG segment is projected to witness a noteworthy growth by 2026"
On the basis of application, the overall market is categorized into a small intestine tumor, Crohn's disease, and obscure gastrointestinal bleeding (OGIB). Among these, the OGIB segment led the market in 2019 and is projected to subjugate the market during the forecast period. This is mainly because OGIB is a condition that without obvious etiology leads to gastrointestinal bleeding. According to MedSpace, capsule endoscopy is extensively used as a first-line and better diagnostic modality for OBIB. Thus, the growing adoption of capsule endoscope for the detection of obscure gastrointestinal bleeding is predicted to surge the segmental growth.
"Hospitals segment to hold the largest market share by 2026"
Based on end-use, the global market is classified into hospitals, pathology laboratories, and outpatient centers. Of these, the hospital segment registered for the largest market share in 2019 owing to the availability of advanced and diverse endoscopic devices. In addition, the presence of skillful healthcare professionals and improved facilities for diagnosing and monitoring of chronic diseases in hospitals is propelling the segmental market growth.
"North America region to grow at a significant rate in the projected timeframe"
Depending on the region, the global industry is divided into Europe, North America, Middle East &Africa, Asia Pacific, and Latin America. The North America region accounted for the largest market share in 2019 and is projected to continue its dominance in the forecast period. This is primarily owing to the growing prevalence rate of colorectal cancer and GI disorders in this region. Besides, rising adoption of minimally invasive endoscopy procedures, the presence of favorable reimbursement policies, and well-established healthcare infrastructure will impel the regional market growth.
On the other hand, the Asia Pacific market for capsule endoscopy is projected to rise at an impressive rate over the period owing to rising demand for minimally invasive procedures due to high unmet needs in the region. Moreover, the increase in gastrointestinal disorders owing to the growing geriatric population in the region is estimated to propel the regional market growth.
The COVID-19 affected patients complain about gastrointestinal tract problems due to nausea and poor appetite. This is ultimately leading to increasing demand for diverse capsules, thereby, driving the growth of the global capsule endoscopy market in these trying times. In COVID-19 patients, the digestive endoscopy is directly contacting the luminal discharge or mucosal secretion and thus, irritates the throat, which leads to choking, vomiting, gagging, and coughing. However, the overall market might foresee a drift in product availability during this pandemic stress mainly due to high costs and lack of skilled medical professionals.
KEY VENDOR TAKEAWA
The leading players of the global capsule endoscopy industry include RF SYSTEM lab, Fujifilm Holding Corporation, IntroMedic Co. Ltd., Olympus, Boston Scientific Corporation, ConMed, Guidant, Olympus, AccuRead Endoscopy Inc., Medtronic, Chongqing Jinshan Science & Technology (Group) Co. Ltd, and CapsoVision. Key players are actively engaged in developing advanced devices with an interface application to eliminate the limitation of traditional devices. These additional features can help the clinician to direct and stop the device into points of interest for diagnosis/detailed inspection, and therapy delivery.
In addition, these players are adopting several strategies such as new product development and mergers & acquisitions to hold a strong position in the global industry. In January 2020, PENTAX Medical announced that it has cleared a CE mark for its product DISCOVERY. It is an innovative artificial intelligence (AI) assisted polyp detector, specially designed to support endoscopists in detecting potential polyps in a colorectal examination.
The market size and forecast for each segment and sub-segments has been considered as below:
Historical Year - 2015 to2018
Base Year - 2019
Estimated Year - 2020
Projected Year - 2026
Traders, Distributors, and Suppliers
Government and Regional Agencies
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
RF SYSTEM Lab
Fujifilm Holding Corporation
IntroMedic Co. Ltd.
Boston Scientific Corporation
AccuRead Endoscopy Inc.
Chongqing Jinshan Science &Technology (Group) Co. Ltd.
CAPSULE ENDOSCOPY MARKET, BY ACCESSORIES
Workstation and Receiver
CAPSULE ENDOSCOPY MARKET, BY ENDOSCOPE TYPE
CAPSULE ENDOSCOPY MARKET, BY PRODUCT
CAPSULE ENDOSCOPY MARKET, BY APPLICATION
Small Intestine Tumor
OGIB (Obscure Gastrointestinal Bleeding)
Others (Celiac Disease, NSAID Reactions)
CAPSULE ENDOSCOPY MARKET, BY END-USE
CAPSULE ENDOSCOPY MARKET, BY REGION
Rest of Europe
Rest of APAC
Rest of LATAM
Middle East and Africa
United Arab Emirates
Rest of MEA